Login / Signup

Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data.

Shigeo ShimoseRie SugimotoAtsushi HiraokaMasatoshi TanakaHideki IwamotoYuki TanakaFujimasa TadaHideko OhamaTakashi NiizekiTomotake ShironoEtsuko MoriyamaYu NodaNaoki KamachiMasahito NakanoRyoko KuromatsuHironori KogaTakumi Kawaguchi
Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
The therapeutic effect of RAM increased in patients with Atezo/Beva failure. Patients with splenomegaly and low BMI should be monitored for ascites during RAM treatment.
Keyphrases
  • body mass index
  • big data
  • cell free
  • weight gain
  • metastatic colorectal cancer
  • bone marrow
  • artificial intelligence